Skip to main content

Jain Vivek's Form 4 filing

Icu Medical Inc (ICUI) · filed Dec 30, 2021

Accession no.
0001410442-21-000010
Filed
Dec 30, 2021
Trade date
Dec 28-30, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.88M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jain VivekCIK 0001410442Director, Officer (Chairman and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 28, 2021Common StockMOption exerciseAcquired+164$58.79+$9,641.5612,943Direct
Dec 28, 2021Common StockSSaleDisposed−164$240.00F2−$39,36012,779Direct
Dec 29, 2021Common StockMOption exerciseAcquired+10,677$58.79+$627,700.8323,456Direct
Dec 29, 2021Common StockSSaleDisposed−10,677$240.00F3−$2,562,48012,779Direct
Dec 30, 2021Common StockMOption exerciseAcquired+1,159$58.79+$68,137.6113,938Direct
Dec 30, 2021Common StockSSaleDisposed−1,159$240.00F2−$278,16012,779Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 28, 2021Common StockMOption exerciseDisposed−164$0.00$0254,202Direct
Dec 29, 2021Common StockMOption exerciseDisposed−10,677$0.00$0243,525Direct
Dec 30, 2021Common StockMOption exerciseDisposed−1,159$0.00$0242,366Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

All shares sold were sold at the exact price disclosed.

Referenced by the price of 2 transactions in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.07, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)